Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
2017 · The Lancet Oncology · 1,113 citations
https://doi.org/10.1016/s1470-2045(17)30777-5
R
Rosie Bradley
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
3.1K
Citations
17
h-index
22
i10-index
Rosie Bradley is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & Dementia and Cognitive Impairment Research & Estrogen and related hormone effects. The author has an h-index of 17, co-authored 37 publications.
ORCID: 0000-0002-0758-4905Papers by this author
worksTrastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
2021 · The Lancet Oncology · 332 citations
https://doi.org/10.1016/s1470-2045(21)00288-6
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy
2025 · The Lancet · 13 citations
https://doi.org/10.1016/s0140-6736(25)01013-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat